CroFab
CroFab
CroFab is a widely used antivenom in the United States, specifically designed to treat envenomations from North American pit vipers, including rattlesnakes, copperheads, and cottonmouths. It is a crucial therapeutic agent in the management of snakebites, which are considered a medical emergency due to the potential for severe systemic effects.
Composition[edit | edit source]
CroFab is composed of purified Fab fragments of immunoglobulin G (IgG) derived from sheep that have been immunized with venom from four species of snakes: the Western Diamondback Rattlesnake (Crotalus atrox), the Eastern Diamondback Rattlesnake (Crotalus adamanteus), the Mojave Rattlesnake (Crotalus scutulatus), and the Cottonmouth (Agkistrodon piscivorus). These Fab fragments are designed to bind to and neutralize the venom components, thereby mitigating their toxic effects.
Mechanism of Action[edit | edit source]
The mechanism of action of CroFab involves the binding of the Fab fragments to venom proteins, which neutralizes their activity and facilitates their clearance from the body. This binding prevents the venom from interacting with its physiological targets, thereby reducing the severity of symptoms and preventing further tissue damage.
Indications[edit | edit source]
CroFab is indicated for the treatment of patients with North American crotalid envenomation. It is used to manage both the local and systemic effects of snakebites, including pain, swelling, coagulopathy, and neurotoxicity.
Administration[edit | edit source]
CroFab is administered intravenously. The initial dose is typically 4 to 6 vials, reconstituted and diluted in normal saline, and infused over a period of 60 minutes. Additional doses may be required based on the patient's response and the severity of the envenomation.
Adverse Effects[edit | edit source]
Common adverse effects of CroFab include hypersensitivity reactions, such as rash and urticaria. Anaphylaxis is a rare but serious potential reaction. Serum sickness, characterized by fever, rash, and arthralgia, may occur days to weeks after treatment.
Efficacy[edit | edit source]
Clinical studies have demonstrated that CroFab is effective in reducing the severity of envenomation symptoms and improving patient outcomes. Early administration is associated with better results, emphasizing the importance of prompt medical attention following a snakebite.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
